Cost-effectiveness analysis of mirvetuximab soravtansine in treating recurrent， platinum-resistant， folate receptor α-positive ovarian cancer

WU Yilai, HE Yinmei, LUAN Jiajie, ZHANG Wen

Chinese Journal of Hospital Pharmacy ›› 2025, Vol. 45 ›› Issue (21) : 2479-2484.

PDF(949 KB)
PDF(949 KB)
Chinese Journal of Hospital Pharmacy ›› 2025, Vol. 45 ›› Issue (21) : 2479-2484. DOI: 10.13286/j.1001-5213.2025.21.09
Drug and Clinical Practice

Cost-effectiveness analysis of mirvetuximab soravtansine in treating recurrent， platinum-resistant， folate receptor α-positive ovarian cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 45(21): 2479-2484 https://doi.org/10.13286/j.1001-5213.2025.21.09

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(949 KB)

Accesses

Citation

Detail
Sections
Recommended
Information
Governed by: China Association for Science and Technology
Sponsored by: Chinese Pharmaceutical Association
Published by: Editorial Office of Chinese Journal of Hospital Pharmacy
ISSN 1001-5213
CN 42-1204/R
Contact
Website Copyright © Chinese Journal of Hospital Pharmacy, All Rights Reserved.
Tel: 027-82836596
E-mail：pharmacy@vip.163.com
Wechat

/

〈 〉